Clinical Trial Update: A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating novel combinations for platinum-refractory extensive-stage small cell lung cancer; the study is completed and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-09-09